These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 164280

  • 1. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
    Levy R, Hurwitz E, Maron R, Arnon R, Sela M.
    Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280
    [Abstract] [Full Text] [Related]

  • 2. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E, Levy R, Maron R, Wilchek M, Arnon R, Sela M.
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [Abstract] [Full Text] [Related]

  • 3. Site-directed tumor chemotherapy.
    Arnon R.
    Compr Ther; 1978 Apr; 4(4):68-73. PubMed ID: 348397
    [Abstract] [Full Text] [Related]

  • 4. Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin.
    Hurwitz E, Maron R, Arnon R, Sela M.
    Cancer Biochem Biophys; 1976 May; 1(4):197-202. PubMed ID: 975021
    [Abstract] [Full Text] [Related]

  • 5. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells.
    Onuma M, Odawara T, Watarai S, Aida Y, Ochiai K, Syuto B, Matsumoto K, Yasuda T, Fujimoto Y, Izawa H.
    Jpn J Cancer Res; 1986 Nov; 77(11):1161-7. PubMed ID: 3025145
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC, Libarati M, Bonmassar E, Cudkowicz G.
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK, Silver HK, Reisfeld RA, Morton DL.
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [Abstract] [Full Text] [Related]

  • 15. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H, Luo Y, Haruta Y, Seon BK.
    Cancer Res; 1988 Aug 15; 48(16):4673-80. PubMed ID: 2969282
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J, Ziegler HW, Kölsch E.
    Immunology; 1981 May 15; 43(1):133-43. PubMed ID: 6265346
    [Abstract] [Full Text] [Related]

  • 20. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW, Cremona P, Leonard C, Stremmel P.
    J Immunol; 1980 Oct 15; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.